SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Anthem Biosciences Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
544449 INE0CZ201020 50.8006126 ANTHEM 0 37,132.09 61.9 10.68 2
Quarters :
ParticularsDec 2025(Rs.Cr)Sep 2025(Rs.Cr)Jun 2025(Rs.Cr)
Gross Sales416.58552.23538.01
Other Operating Income0.000.000.00
Other Income 39.9253.8027.73
Total Income456.50606.03565.74
Total Expenditure 278.51326.57342.58
PBIDT177.98279.45223.16
Interest 1.132.231.61
PBDT176.86277.22221.55
Depreciation26.7523.9222.61
Tax37.7863.7550.07
Fringe Benefit Tax0.000.000.00
Deferred Tax0.21-8.880.53
Reported Profit After Tax112.12198.43148.34
Extra-ordinary Items -18.660.000.00
Adjusted Profit After Extra-ordinary item130.78198.43148.34
    
EPS (Unit Curr.)2.003.542.65
EPS (Adj) (Unit Curr.)2.003.542.65
Calculated EPS (Unit Curr.)2.003.532.65
Calculated EPS (Adj) (Unit Curr.)2.003.532.65
Calculated EPS (Ann.) (Unit Curr.)7.9914.1310.61
Calculated EPS (Adj) (Ann.) (Unit Curr.)7.9914.1310.61
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity112.32112.32111.82
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)42.7250.6041.48
PBDTM(%)42.4650.2041.18
PATM(%)26.9135.9327.57